表現型マウス肺機能インビボ肺拡散能力を持つ

Executive Industry Relevance

Measuring lung diffusing capacity in mice provides a translational pulmonary function test that enables direct comparison with human clinical data. This approach supports phenotypic characterization of lung disease models and enhances predictive confidence in preclinical target validation. The method’s simplicity and reproducibility facilitate integration into discovery workflows for mechanistic de-risking and portfolio triage.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Scientific Value: Enables interrogation of therapeutic hypotheses by quantifying lung function loss across emphysema, fibrosis, acute lung injury, and infection models.
• Operational Value: Provides a rapid, reproducible assay for functional target validation in murine lung pathology studies.

Screening & Assay Development

• Scientific Value: Delivers quantitative, gas-exchange-based readouts suitable for screening compound effects on lung structure and function.
• Operational Value: Standardized procedure with <1-minute readout supports high-throughput phenotypic screening in discovery pipelines.

Translational & Preclinical Research

• Scientific Value: Aligns with human diffusing capacity measurements, enabling cross-species biomarker alignment and translational continuity.
• Operational Value: Supports risk-adjusted advancement decisions by detecting early functional changes in preclinical models.

Pipeline & Workflow Integration

The method fits within the discovery continuum from target validation through lead identification to preclinical efficacy testing, offering a phenotypic bridge between murine models and human clinical endpoints.

• Discovery Biology: Supports hypothesis testing and pathway clarification by detecting structural lung changes via functional gas exchange metrics.
• Screening: Enables assay readiness through standardized gas collection and chromatographic analysis of neon and carbon monoxide uptake.
• Analytics: Generates quantitative diffusing capacity (DFCO) values that allow comparison of lung function across experimental conditions and time points.
• Translational Research: Connects murine phenotypes to human clinical relevance through direct comparability of diffusing capacity measurements.
• Enterprise Reuse: Represents a reusable capability for longitudinal lung function monitoring across multiple disease models and study phases.

Operational & Enterprise Impact

• Scientific Value: Increases predictive confidence by reducing mechanistic ambiguity in lung pathology models through quantitative phenotyping.
• Operational Value: Enhances standardization and reproducibility via rapid gas injection, breath-hold, and GC analysis workflow.
• Strategic Value: Improves go/no-go decisions by providing early, translationally relevant functional readouts that reduce late-stage biological risk.
• Portfolio Impact: Enables risk-based prioritization of compounds based on lung function preservation or improvement in disease models.

Implementation Considerations

• Requires expertise in mouse anesthesia, tracheal cannulation, and gas handling techniques.
• Dependent on access to a calibrated gas chromatograph with molecular sieve column and helium carrier gas.
• Necessitates cross-team standardization of gas volumes, inflation timing, and sample dilution protocols.
• Involves adaptation considerations for neonatal vs. adult mice due to lung size and required gas volumes (0.4 mL vs. 0.8 mL).
• Includes practical limitations such as the need to prevent sample contamination during transfer and the importance of rapid lung inflation/deflation for accurate measurements.

Biopharma FAQs